MedTrace Logo

The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation

NCT00826826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2014-03-05

No results posted yet for this study

Summary

The purpose of this study is to examine the overall effectiveness of short-time anti-arrhythmic drug treatment with amiodarone (to control heart rhythm) to prevent short-and long-term atrial fibrillation following an ablation procedure for atrial fibrillation.

Conditions

Interventions

PROCEDURE

Catheter ablation

(Pulmonary vein isolation)

DRUG

Amiodarone

From the day of the catheter ablation procedure and 8 weeks forward.

DRUG

Placebo

From the day of the catheter ablation procedure and 8 weeks forward.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Stine Darkner, MD · Rigshospitalet, Denmark

  • Jesper H Svendsen, MD, DMSc · Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00826826 on ClinicalTrials.gov